| Thomas Boyer, MD |
A Safety and Efficacy Study of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 |
|
| Thomas Boyer, MD |
A Study to Describe the Antiviral Effect of Entecavir (ETV) in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection Who Are Nucleoside-Naïve |
|
| Thomas Boyer, MD |
Eltrombopag to Initiate and Maintain Interferon Antiviral Treatment to Subjects With Hepatitis C Related Liver Disease (Enable 1 and Enable 2) |
|
